Clinical trial
Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients
NCT06447532 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients
- Lead sponsor
- Federal University of São Paulo
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 1, 2024
- Completion date
- February 28, 2027
- Enrollment
- 4,500 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer